.webp/jcr:content.webp)
Cardiovascular Diseases
Learn about the latest trends, discover events and innovations in the changing world of cardiovascular disease.
Science in Cardiovascular Diseases
Get a 360º view and stay up-to-date on cardiovascular disease with content selected for you
Acute LDL-C Reduction Post ACS: Strike Early and Strike Strong: From Evidence to Clinical Practice
Management of Patients With Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: 1-year Outcomes of The PERI-DYS Study
Prospective evaluation of lipid management following acute coronary syndrome in Saudi Arabia
Hypercholesterolemia Treatment Patterns and Lipid Target in ACS Patients: HYDRA-ACS Registry
-from-the-SAFEHEART-registry.webp/jcr:content/Clinical%20practice%20experience%20in%20patients%20with%20familial%20hypercholesterolemia%20(FH)%20from%20the%20SAFEHEART%20registry.webp)
Clinical practice experience in patients with familial hypercholesterolemia (FH) from the SAFEHEART registry
Proprotein convertase subtilisin/kexin type 9 inhibitors for heterozygous familial hypercholesterolemia: A clinical practice experience from the SAFEHEART registry
Inspiration and innovation
Get inspired and stay at the forefront of innovation with the following resources
Risk for Pulmonary Embolism Continues Beyond 6 Weeks of Surgery
Guidelines recommend postoperative prophylactic anticoagulation for 1-5 weeks.
VTE Comparison of Pregnancy - Specific Risk Scoring Systems in Hospitalized Maternity Patients
Large prospective clinical trials are needed to validate the scoring threshold for pharmacoprophylaxis.
.png/jcr:content/jcr_content%20(43).png)
Events
Stay up to date and register for the latest events and view webinar recordings
.jpg/jcr:content/image%20(5).jpg)
VTE Safety Zone: Prof. Juan Arcelus - Primary VTE Prophylaxis in Patients with Cancer Undergoing Major Abdominal/Pelvic Surgery
VTE Safety Zone: VTE in general surgery from risk assessment to appropriate thromboprophylaxis
